期刊文献+

HPLC法测定猪尿酸酶活性 被引量:2

Determination of Pig-Uricase Enzyme Activity by HPLC
下载PDF
导出
摘要 建立了一种测定重组猪尿酸酶活性的高效液相色谱方法。将重组猪尿酸酶基因工程菌的粗酶液与尿酸溶液反应5min,加入高氯酸溶液终止,经超滤后以体系中尿酸浓度的降低值为指标,采用HPLC法[色谱条件:AgilentZorbax 300SB-C18色谱柱、流动相为磷酸-甲醇-双蒸水(3∶25∶472,体积比)、流速1.0mL·min-1、波长292nm]测定粗酶液活性。结果表明,尿酸在10~500μmol·L-1范围内线性关系良好,样品回收率在99%~104%之间。该方法不受杂质干扰、稳定、灵敏度高,适用于尿酸酶粗酶液活性的检测。 A HPLC method for determining the activity of fermentation liquor of recombinant E. coli ex- pressing pig-uricase was established. The fermentation liquor was reacted with uric acid for 5 min,then the reac- tion was terminated by adding perchloric acid. The analysis was conducted by HPLC after ultrafiltration using Agilent Zorbax 300SB-C,s column with a mobile phase consisting of phosphoric acid-methanol-water(3 :25 : 472,volume ratio). The flow rate was 1.0 mL. min^-1 and the wavelength was 292 nm. The enzyme activity of fermentation liquor was calculated indirectly by lowering the concentration of uric acid. The calibration curve of uric acid concentration displayed highly relative linearity over the range of 10-500μmol. L^-1. The recovery was 99-104%. The method is stable, sensitive, and is not disturbed by impurities. It's suitable for determi- ning activity of crude enzyme.
出处 《化学与生物工程》 CAS 2012年第6期88-91,共4页 Chemistry & Bioengineering
基金 国家自然科学基金资助项目(81072560)
关键词 基因工程菌 尿酸酶 酶活性 高效液相色谱 genetic engineering bacteria uricase enzyme activity high performance liquid chromatography(HPLC)
  • 相关文献

参考文献5

二级参考文献45

  • 1Body A, Sonet A, Pinkerton C R, et al. Rasburicase ( recombinant urate oxidase) for the management of hyperuricemia in patients with study cancer; report of an international compassionate use study [ J ]. Cancer, 2003,98(5) :1048.
  • 2Yeldandi A V, Yeldandi V , Kumar S. Molecular evolution of the urate oxidase-encoding gene in hominoid primates : nonsense mutations [ J ]. Gene , 1991,109 (2) :281.
  • 3Yeldandi A V,Wang X D , Alvarea K. Hunman urate oxidase gene:cloning and partial aequense analysis reveal a stop condon within the fifth exon [ J ]. Biochem Biophys Res commun, 1990,172(2) :641.
  • 4Miller D A , Freeman G L , Akers W A. Chronic urticaria. Aclinical study of fifty patients[ J]. Am J Med, 1968, 45: 6977.
  • 5Sundy J S, Hershfield M S. Uricase and other novel agents for the management of patients with treatmentfailure gout [J]. Curr Rheumatol, 2007,9: 258.
  • 6Reddy K R. Controlleed-release, pegylation, liposomal formutations new mechanisms in the delivery of injectable drugs [J]. Ann Pharmacother, 2000, 34 (2) :915.
  • 7Sherman M R, Saifer M G, Perez-Ruiz F. PEG-uricase the management of treatment-resistant gout and hyperuricemia [ J ]. AdvDru Deliv Rev, 2008,60:59.
  • 8刘国安,刘沐荣,康经武.尿酸氧化酶的酶活性分析方法[P].中国专利:20061004907[2006-10-4].
  • 9陈灏珠.内科学[M] 4版[M].北京:人民卫生出版社,1996.667.
  • 10Seo HC, Willems PJ, Kretz KA, Martin BM, O'Brien JS.Fucosidosis: four new mutations and a new polymorphism.Hum Mol Genet 1993;2:423-429.

共引文献7

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部